Tuesday, March 17, 2026

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Nexon Unleashes KHAZAN in Early Access—Fans Are Loving It

Nexon launches early access for action RPG The First Berserker: KHAZAN, offering exclusive rewards and positive player feedback.

LG Display CEO Calls Cost Innovation ‘Survival Condition’ Amid Market Challenges

LG Display CEO Jeong Cheol-dong emphasizes cost innovation and quality for business survival, urging teamwork to overcome challenges ahead.

Tag: CG MedTech

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Novosis Trauma: The Game-Changing Bone Substitute Approved in Malaysia

CG MedTech's Novosis Trauma, a bone substitute for fractures, gains approval in Malaysia, marking its first international registration.

CG MedTech’s Spine System Gets U.S. Debut in Texas Surgery

CG MedTech's INNOVERSE Spinal System gains FDA clearance and is successfully used in surgeries, marking a milestone for Korean medical devices.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.